Email
info@comserveonline.com
Shibuya-ku, Tokyo, Japan, Japan, Jan 05, 2022, 02:08 /Comserve / -- The Computer-Aided Drug Discovery market size accounted for more than $1,540.4 million in 2018 and is estimated to witness a lucrative growth of over 15.5% during the forecast period.
The Computer-Aided Drug Discovery market size accounted for more than $1,540.4 million in 2018 and is estimated to witness a lucrative growth of over 15.5% during the forecast period.
Huge investments are being done by the key manufacturers in Computer-Aided Drug Discovery market for R&D activities to develop new drugs for various diseases such as cardiovascular diseases and oncology and is expected to drive the global computer-aided drug discovery market in the near future.
For More Information About This Report Visit:- https://www.sdki.jp/sample-request-104950
Based on Type, the Computer-Aided Drug Discovery market is categorized into Structure Based Drug Design (SBDD), Ligand-Based Drug Design (LBDD) and Sequence-Based Approaches. Ligand-based drug design segment is anticipated to drive the market growth in the recent years and is expected to reach $1,878.2 million growing at a CAGR of 15.2% during the projected time frame.
Computer-Aided Drug Discovery market based on therapeutic area is divided into oncology, neurology, cardiovascular disease, respiratory disease and diabetes among others. Oncology segment held the largest market value accounting for more than $355.8 million in 2018. However, cardiovascular disease segment is expected to boost the global Computer-Aided Drug Discovery market in the recent years and value for $917.2 million in 2018, boosting at a CAGR of 15.8% by 2026.
On the basis of end-user, the computer-Aided Drug Discovery market is segmented into pharmaceutical companies, biotechnology companies and research institutes. Research Institute is expected to lead the market in the year 2018 accounting for $602.3 million and is anticipated to continue its dominance during the forecast period. The research institutes segment is expected to account for $1,873.4 million by 2026 growing at CAGR of % during the forecasted period.
Depending on the region, the market is segregated into North America, Europe, Asia-Pacific and LAMEA. North America region accounted for $432.9 million in 2018 and is estimated to continue its dominance during the forecasted period. This growth is majorly due to the biotechnology and pharmaceutical industry, increased use of personalized medicine, a large number of ongoing drug development processes, and rising R&D expenditure by pharmaceutical and biotechnology companies.
For More Information About This Report Visit:- https://www.sdki.jp/sample-request-104950
The key market players in Computer -Aided Drug Discovery market include Albany Molecular Research Inc. (AMRI), BioDuro, Charles River, Schrödinger, Aragen Bioscience, Aris Pharmaceuticals, AstraZeneca, BOC Sciences, Evotec A.G., and Bayers AG among many others.
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Lauren BrownShibuya Data Count
Email: sales@sdki.jp
Tel: + 81 50 50509159
Related Links
https://www.sdki.us/
